# Bayer shares rally; €3 bn Apollo LARC boost > Live situation record from CLSTR: https://clstr.news/situations/us-courts-grapple-with-major-telecom-privacy-and-chemical-liability-cases > Updated: 2026-08-04T10:20:00.000Z. Sources: 140. Developments: 26. Following the July 10 €3 bn Apollo investment in Bayer’s LARC unit, the company secured a series of legal and commercial wins that kept its share price on an upward trajectory. In late June, the U.S. Supreme Court issued a 7‑2 ruling that pre‑empted state‑law cancer‑warning claims over Roundup, prompting Bayer’s stock to jump 15‑23 % across Europe and the U.S. and prompting analysts to lift price targets to €54‑€60. The decision also cleared the path for a pending $7.25 bn settlement. Around the same time Bayer intensified its U.S. litigation strategy, filing motions to keep the multidistrict case in Missouri and winning a federal judge’s dismissal of a procedural challenge, which added another 5 % to the share price. The firm also announced a €5 bn allocation for glyphosate‑related settlements and launched an AI‑driven drug‑discovery partnership with Iambic Therapeutics. Regulatory progress continued with FDA approval of two MRI contrast agents, while a German court ruled Bayer’s net‑zero pledge misleading, linking the judgment to its glyphosate business. Bayer re‑organized its U.S. glyphosate operations into a new Ruveon subsidiary and filed antidumping petitions against Chinese imports. Share performance remained strong – a 191 % rise since April 2025 and a July 3 bounce to €48‑€53 – even as analysts warned of over‑bought technical signals. In early August, Bayer posted a Q2 profit beat, driven by strong Crop Science and pharmaceutical sales, while the $7.25 bn settlement hearing remains scheduled for later in the year. ## Timeline ### 2026-08-04: Bayer posts strong Q2 earnings and raises outlook amid glyphosate lawsuit Bayer beats Q2 expectations with €219 million profit and raises outlook despite a glyphosate lawsuit; SAP launches €344 million buyback as cloud sales surge; Merck lifts 2026 revenue target but cuts EPS after T 8 sources. https://clstr.news/cluster/bayer-beats-q2-forecasts-shares-jump-as-glyphosate-lawsuit-looms ### 2026-07-13: Bayer triumphs in US Supreme Court glyphosate case as pesticide approvals broaden The US Supreme Court limited lawsuits against Bayer over Roundup glyphosate, boosting its shares, as the company also consolidates its business and secures new pesticide approvals. 6 sources. https://clstr.news/cluster/bayer-triumphs-in-us-supreme-court-glyphosate-case-as-pesticide-approvals-broaden ### 2026-07-11: Bayer shares surge after US Supreme Court clears glyphosate liability US Supreme Court cleared Bayer of glyphosate liability, sending its shares up ~20% and up 81% over a year, though the rally now steadies amid pending lawsuits. 2 sources. https://clstr.news/cluster/bayer-shares-surge-after-us-supreme-court-clears-glyphosate-liability ### 2026-07-10: Bayer secures €3 billion from Apollo to fund contraceptives unit Bayer raises €3 billion from Apollo, selling a minority stake in its LARC contraceptives unit while keeping majority control, to boost liquidity amid Roundup litigation costs. 10 sources. https://clstr.news/cluster/bayer-secures-3-billion-capital-boost-through-apollo-pharma-joint-venture ### 2026-07-09: U.S. Supreme Court blocks state Roundup warnings, reshaping pesticide lawsuits The Supreme Court barred state‑required Roundup warnings, altering pesticide litigation, while a North Carolina jury found an Uber driver liable for battery in ongoing multidistrict litigation. 2 sources. https://clstr.news/cluster/us-supreme-court-blocks-state-roundup-warnings-reshaping-pesticide-lawsuits ### 2026-07-07: U.S. Supreme Court Limits State Laws on Roundup Herbicide Labeling The Supreme Court’s 7‑2 ruling blocks state failure‑to‑warn suits over EPA‑approved Roundup labels, a win for Bayer‑Monsanto. Lawmakers have introduced the People Over Poison Act to restore labeling warnings. 3 sources. https://clstr.news/cluster/us-supreme-court-limits-state-laws-on-roundup-herbicide-labeling ### 2026-07-07: Bayer shares jump after US Supreme Court curtails glyphosate lawsuits and analysts lift price targets US Supreme Court limits Bayer glyphosate lawsuits; analysts raise price targets to €55‑60, boosting shares above €50 as the firm plans a U.S. spin‑off. 3 sources. https://clstr.news/cluster/bayer-shares-jump-after-us-supreme-court-curtails-glyphosate-lawsuits-and-analysts-lift-price-target ### 2026-07-05: Bayer and TKMS Stocks Jump on Legal Wins and Technical Gains Bayer’s shares double amid overbought signals and major legal moves, including a $7.25 bn Roundup settlement delay, while German defence firm TKMS climbs 11 % as technical indicators turn bullish. 2 sources. https://clstr.news/cluster/bayer-and-tkms-stocks-jump-on-legal-wins-and-technical-gains ### 2026-07-05: US Supreme Court blocks state‑law cancer warnings in Roundup case The U.S. Supreme Court ruled that federal pesticide law bars state‑law cancer‑warning claims against Bayer’s Roundup, halting thousands of lawsuits and reducing the company’s liability. 2 sources. https://clstr.news/cluster/us-supreme-court-blocks-statelaw-cancer-warnings-in-roundup-case ### 2026-07-03: Bayer shares jump 191% since April, analysts set modest price targets Bayer’s shares have climbed about 191 % since April 2025, hitting key resistance levels. Analysts (8 buy, 3 hold) set an average target of €49.23 versus a current price of €48.41, noting mixed technical signals 3 sources. https://clstr.news/cluster/bayer-shares-jump-191-since-april-analysts-set-modest-price-targets ### 2026-07-01: Bayer restructures US glyphosate business into Ruveon unit and seeks tariffs on Chinese imports Bayer created the Ruveon unit to run its U.S. glyphosate business and filed a petition for antidumping duties on Chinese imports, prompting farmer opposition. 9 sources. https://clstr.news/cluster/bayer-moves-us-glyphosate-business-to-ruveon-and-seeks-antidumping-tariffs-on-chinese-imports ### 2026-06-29: Bayer/Monsanto Shielded from Roundup Cancer Lawsuits by US Supreme Court US Supreme Court ruled 7‑2 that federal law blocks state Roundup cancer lawsuits, shielding Bayer/Monsanto and prompting Bayer to seek tariffs on Chinese glyphosate, sparking farmer opposition. 13 sources. https://clstr.news/cluster/us-supreme-court-blocks-roundup-glyphosate-warning-lawsuits ### 2026-06-28: Bayer shares surge after US Supreme Court blocks glyphosate warning lawsuits The U.S. Supreme Court ruled 7‑2 that federal law preempts state glyphosate warning claims, shielding Bayer’s Roundup. Bayer shares jumped up to 23 % as analysts lifted targets, though existing settlements and债 9 sources. https://clstr.news/cluster/us-supreme-court-blocks-state-cancer-warning-claims-against-roundup ### 2026-06-26: U.S. Supreme Court bars state cancer warnings for Roundup pesticide The Supreme Court ruled 7‑2 that federal pesticide law preempts state cancer‑warning lawsuits against Monsanto’s Roundup, keeping EPA‑approved labeling in place. 2 sources. https://clstr.news/cluster/us-supreme-court-bars-state-cancer-warnings-for-roundup-pesticide ### 2026-06-26: German court upholds ruling against Bayer's misleading net‑zero pledge A Cologne court upheld DUH's ruling that Bayer’s net‑zero pledge was misleading, ordering a stop to deceptive climate ads and demanding transparent reporting and a glyphosate exit. 2 sources. https://clstr.news/cluster/german-court-upholds-ruling-against-bayers-misleading-netzero-pledge ### 2026-06-25: Bayer shares rise as US Supreme Court limits glyphosate liability Bayer stock climbs after the US Supreme Court limits glyphosate liability; Jefferies raises the target price to €46 but maintains a hold rating. 2 sources. https://clstr.news/cluster/bayer-shares-rise-as-us-supreme-court-limits-glyphosate-liability ### 2026-06-25: Bayer Wins U.S. Supreme Court Ruling Blocking Thousands of Roundup Lawsuits The Supreme Court ruled that federal law preempts state claims over Roundup labeling, overturning a $1.25 M verdict and blocking thousands of lawsuits; Bayer hailed the decision, while health advocates decried​ 78 sources. https://clstr.news/cluster/us-supreme-court-blocks-thousands-of-roundup-lawsuits ### 2026-06-23: U.S. Supreme Court Shields Pesticide Makers from Roundup Cancer Lawsuits The Supreme Court ruled that federal law preempts state cancer lawsuits against Bayer and other pesticide makers over Roundup, shielding them from liability and prompting calls for congressional action. 2 sources. https://clstr.news/cluster/us-supreme-court-shields-pesticide-makers-from-roundup-cancer-lawsuits ### 2026-06-22: Bayer confronts €5 bn glyphosate legal burden as it launches AI drug‑discovery partnership Bayer faces €5 bn glyphosate legal costs while expanding in China and launches an AI drug‑discovery partnership with U.S. firm Iambic Therapeutics. 2 sources. https://clstr.news/cluster/bayer-confronts-5-bn-glyphosate-legal-burden-as-it-launches-ai-drugdiscovery-partnership ### 2026-06-16: Bayer secures FDA approval for two MRI contrast agents as US glyphosate lawsuit hurdle is cleared Bayer got FDA approval for two MRI contrast agents and a US judge cleared a procedural hurdle in its $7.25 bn glyphosate lawsuit, boosting the stock. 2 sources. https://clstr.news/cluster/bayer-secures-fda-approval-for-two-mri-contrast-agents-as-us-glyphosate-lawsuit-hurdle-is-cleared ### 2026-06-16: Bayer and Adidas stocks react to legal battles and World Cup boost Bayer shares stabilize modestly amid U.S. glyphosate lawsuits, while Adidas gains on strong earnings and World Cup prospects, with analysts targeting €40.5 and €211 respectively. 2 sources. https://clstr.news/cluster/bayer-and-adidas-stocks-react-to-legal-battles-and-world-cup-boost ### 2026-06-05: Bayer adopts new legal tactics in US glyphosate lawsuits ahead of Supreme Court ruling Bayer files new motions to shift US glyphosate lawsuits to Missouri court and braces for a Supreme Court decision, calling the outcome business‑decisive; shares rise 1.5%. 4 sources. https://clstr.news/cluster/bayer-ramps-up-legal-tactics-ahead-of-us-supreme-court-glyphosate-decision ### 2026-06-02: Bayer faces US court shift as EU pesticide reforms spark health concerns Bayer's glyphosate settlement faces a June opt‑out deadline and a US court move to San Francisco, while the German Leopoldina warns EU plans to loosen pesticide approvals could endanger health. 2 sources. https://clstr.news/cluster/bayer-faces-us-court-shift-as-eu-pesticide-reforms-spark-health-concerns ### 2026-05-14: Glyphosate Herbicide Faces Health Scrutiny as Homegrown Weed Control Gains Attention Glyphosate's cancer risk sparks lawsuits and home‑grown weed‑killer alternatives. 2 sources. https://clstr.news/cluster/glyphosate-herbicide-faces-health-scrutiny-as-homegrown-weed-control-gains-attention ### 2026-05-05: Bayer's Roundup lawsuits face Supreme Court challenge and contested Missouri settlement Bayer's Roundup faces a Supreme Court immunity challenge and a disputed $7.25 B Missouri settlement, with judges questioning future claim coverage. 5 sources. https://clstr.news/cluster/bayers-roundup-lawsuits-face-supreme-court-challenge-and-contested-missouri-settlement ### 2026-04-27: US Supreme Court weighs limits on glyphosate lawsuits over Roundup cancer claims US Supreme Court weighs federal preemption in glyphosate cancer lawsuits against Roundup. 4 sources. https://clstr.news/cluster/us-supreme-court-weighs-limits-on-glyphosate-lawsuits-over-roundup-cancer-claims --- Cite as: Bayer shares rally; €3 bn Apollo LARC boost. CLSTR, https://clstr.news/situations/us-courts-grapple-with-major-telecom-privacy-and-chemical-liability-cases